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Glucocorticoids affect the composition and function of the plasma membrane in 
a variety of cell types.' Incubation of HTC cells, an established line of rat hepatoma 
cells in tissue culture, with the synthetic glucocorticoid dexamethasone (DEX) alters 
several membrane properties characteristic of transformed cells, without affecting the 
growth rate of these cells. Dexamethasone rapidly and reversibly inhibits the active 
transport of selected amino increases the adhesiveness of the cells to a plastic 
or glass substrate by a process that requires macromolecular and rapidly 
and dramatically inhibits the activity of plasminogen activator (PA), a serine protease, 
which may itself modulate other membrane proper tie^.'^'^ 
HTC cells provide a favorable experimental system for the investigation of the 
hormonal regulation of membrane phenotype. The effects of individual hormones, 
either in isolation or in combination, can be studied in a fashion that is not possible 
in the intact animal. An established cell line offers the ease of experimental manip- 
ulation and stability under a variety of experimental conditions, not usually available 
in freshly-isolated dissociated cells or in primary cultures of liver cells. The ability to 
grow HTC cells in suspension culture reduces the need for manipulations such as 
trypsinization, which can affect transport and other membrane processes. HTC cells 
have been studied intensively with regard to glucocorticoid receptor function and 
induction of tyrosine aminotransferase which further enhances their 
usefulness for our studies. Finally, as discussed in this communication, it is possible 
to isolate steroid-resistant variant lines of HTC cells allowing the application of both 
genetic and biochemical techniques to the study of the hormonal regulation of 
membrane properties in these liver-derived cells. 
Glucocorticoid Regulation of Amino Acid Transport in HTC Cells 
We have studied the transport of amino acids by HTC cells in suspension culture 
utilizing the model amino acid a-aminoisobutyric acid (AIB). AIB is transported in 
a number of tissues by the so-called A, or alanine-preferring, system for neutral 
amino acids.I7 Following uptake, AIB is neither incorporated into protein nor 
catabolized; hence its transport can be studied independently of the complications 
introduced by such intracellular metabolism. Subsequently, we have extended our 
studies to the hormonal modulation of the transport of natural amino acids. HTC 
cells in suspension culture in a chemically-defined, serum-free medium containing 
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essential amino acids and glucose, actively transport AIB by saturable, stereospecific, 
energy-dependent process. Distribution ratios greater than 20 are achieved at AIB 
concentrations of less than 0.5 mM. A single sodium-dependent transport system 
appears to mediate the bulk of AIB uptake. The apparent Km for this system is I to 
3 mM.2,s 
Dexamethasone rapidly and dramatically decreases the influx of AIB. Following 
a lag of approximately one-half hour, the initial rate of transport decreases exponen- 
tially to approximately 20% of control after 6 hours, and 10% after 18 hours 
incubation with hormone. Inhibition is half-maximal within 90 to 120 minutes 
(FIGURE 1). The inhibition of AIB transport by dexamethasone reflects a decrease in 
the capacity of the transport system, or its Vmax, without significant change in the 
apparent Km of the transport Removal of the hormone by washing and 
resuspension of the cells in glucocorticoid-free medium, reverses the inhibition of 
AIB transport. Recovery of control rates of transport occur within a roximately 20 
hours; half-maximal recovery requires approximately 5 to 6 hours!'Incubation of 
dexamethasone-treated cells with insulin results in a rapid, strikin stimulation of 
AIB transport to or near control levels within 2 hours incubation. Jt? 
Mechanism of Glucocorticoid Inhibition of Transport 
The mechanism of the transport inhibition has been explored using a variety of 
inhibitors. Neither colcemid nor cytochalasin B, at concentrations sufficient to 
disaggregate microtubules and microfilaments, respectively, interferes with AIB 
transport nor its inhibition by dexamethasone. Thus, cytoskeletal elements do not 
appear to play an important role in the hormonal inhibition of AIB transport.' 
Complete (>98%) inhibition of protein synthesis by 0.1 mM cycloheximide blocks 
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FIGURE I.  Schematic time course of the hormonal regulation of AIB transport in HTC 
cells. Velocity (AIB) indicates the initial rate of influx of AIB measured during a 5 to 10 minute 
incubation with [14C]-AIB. Data are expressed on an arbitrary scale of 0 to 1.0. Time indicates 
time of incubation with hormone. The arrow at 18 hours indicates addition of insulin to 
dexamethasone-treated cells, or removal of dexamethasone by washing and resuspension of 
cells in hormone-free medium. The effect of both of these experimental treatments was 
completely blocked by 0.1 mM cycloheximide. Based on data from references 2.4 and 18, plus 
unpublished observations. (From Gelehrter.' By permission of Springer-Verlag.) 
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the dexamethasone inhibition of transport. Curiously, cycloheximide alone only 
minimally inhibits the uptake of AIB. Cycloheximide also blocks the recovery of 
AIB transport following removal of dexamethasone. Furthermore, addition of cyclo- 
heximide 30, 60, or 120 minutes after the addition of dexamethasone completely 
prevents any further inhibition of AIB transport by the glucoc~rticoid.~ Lower 
concentrations of cycloheximide ( 1  pM), which inhibit amino acid incorporation into 
protein by 40% to 60%, do not prevent the dexamethasone inhibition of AIB 
transport, but do inhibit transport in the absence of dexamethasone. 
Studies using actinomycin D to inhibit RNA synthesis have yielded similar 
results. Concentrations of actinomycin (0.2 pM) sufticient to inhibit the incorporation 
of uridine into RNA by 90% to 9596, inhibit AIB transport but do not interfere with 
the inhibition by de~amethasone.~ Higher concentrations of actinomycin D (4 pM), 
which block uridine incorporation by more than 95% (and cause “superinduction” 
of tyrosine aminotran~ferase’~) cause only a modest inhibition of AIB transport in 
control cells but completely prevent the dexamethasone inhibition of AIB transport; 
results similar to those obtained with 0. I mM cy~loheximide.~ 
High concentrations of both cycloheximide and actinomycin D have been re- 
ported to interfere with rotein degradation in HTC cells and other rat hepatoma 
cells in tissue culture?”2QWe feel that the experimental results described above are 
most compatible with the hypothesis that dexamethasone accelerates the degradation 
of some rate-limiting component of the AIB transport system. In the presence of 
high concentrations of cycloheximide or actinomycin D, degradation is blocked, and 
DEX action inhibited. This explanation is also consistent with the time course of the 
dexamethasone inhibition and its reversal after removing dexamethasone. It should 
be noted that an effect on degradation would result in more rapid changes in 
transport than a comparable effect on the rate of synthesis, since the time course of 
change from one steady state to another is a function only of the rate of degradation 
of the relevant protein.24 
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Steroid Specificity of the Glucocorticoid Inhibition of Transport 
We have also investigated the relationship between steroid structure and inhibi- 
tion of AIB transport, and compared this with the steroid specificity of induction of 
tyrosine amin~transferase~~ and binding to specific cytoplasmic glucocorticoid recep- 
torsz6 Our observations support the model of a common receptor system in the 
mechanism of action of glucocorticoids in HTC cells. Dexamethasone and cortisol, 
which are full agonists with respect to transaminase induction, are also full agonists 
with respect to transport inhibition. The concentrations required for half-maximal 
inhibition of transport, 5 nM for dexamethasone and 60 nM for cortisol, correspond 
almost exactly to those required for half-maximal induction of tyrosine aminotrans- 
ferase. Tetrahydrocortisol, an inactive steroid because it neither binds to the cyto- 
plasmic receptor nor induces transaminase, has no affect on either AIB transport or 
its inhibition by dexamethasone. Curiously, 1 1 -P-hydroxyprogesterone and deoxy- 
corticosterone, which are partial agonists or “suboptimal inducers” of tyrosine 
aminotransferase, are, at sufficiently high concentrations, full agonists with respect 
to transport inhibition. Even 17-a-methyltestosterone, an “anti-inducer” of tyrosine 
aminotransferase, causes significant inhibition of AIB transport at high concentra- 
tions (0.1 mM). Competition experiments, in which the effects of increasing concen- 
trations of partial agonists or antagonists together with a constant concentration of 
full agonist are examined, confirm the above results. The inhibition of amino acid 
transport by steroids that are partial agonists or antagonists for transaminase induc- 
tion is not a generalized toxic effect of high concentrations of these steroids. Rather, 
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they appear to share with dexamethasone common mechanisms of action in terms of 
their time course, reversibility, and inhibition by cycloheximide and actinomycin 
D.27 These observations imply more complexity then is currently encoded in the 
steric-allosteric model of steroid hormone action,% or in the nature of the post- 
receptor events as described by the widely accepted induction model of glucocorticoid 
a ~ t i o n . ’ ~ ” ~  
Role of the Nucleus in Glucocorticoid Regulation of Transport 
It is generally believed that nuclear localization of steroid-receptor complexes is 
necessary for their biological  action^'^; however, the possibility that steroid-receptor 
complexes may have nonnuclear actions has not been excluded. At present there is 
direct evidence for nuclear localization of only full agonist glucocorticoids in HTC 
cells, and indeed there is some evidence that antagonists or anti-inducers do not enter 
the nucleus.29 In order to study the possibility that the dexamethasone-receptor 
complex might have direct cytoplasmic actions, we have examined the dexametha- 
sone regulation of AIB transport in anucleate HTC cells. HTC cells were enucleated 
by centrifugation through Ficoll gradients containing 10 pg/ml cytochalasin B.30 
Preparations of cytoplasts containing more than 96% anucleate cells in yields of 
approximately 60% could be obtained readily. Washed cytoplasts could be main- 
tained in suspension in serum-free medium for more than 24 hours without loss of 
membrane integrity, as assessed by the exclusion of trypan blue. Anucleate HTC 
cells transport AIB with initial rates of uptake equal to or greater than those of intact 
cells, for as long as 24 hours in culture. The time course of uptake and the kinetics 
of AIB transport are the same as those of intact cells. Dexamethasone, however, 
completely fails to inhibit AIB uptake in cytoplasts. Transport was also unaffected 
by deoxycorticosterone and 1 I -P-hydroxyprogesterone at concentrations that pro- 
duced maximal inhibition of transport in nucleated ~ells.~’~3’ The failure of dexa- 
methasone inhibition of transport in anucleate HTC cells could not be accounted for 
by the decreased level of total protein synthesis in anucleate cells, nor by absence of 
specific glucocorticoid receptors. Thus the nucleus appears to be required for the 
glucocorticoid regulation of AIB transport in HTC cells. This may reflect the 
requirement for direct nuclear action of glucocorticoids, or a requirement for the 
nucleus for the maintenance of normal rates of protein d e g r a d a t i ~ n . ~ ~  
Amino Acid Specifcity of Glucocorticoid Inhibition of Transport 
Dexamethasone also inhibits the initial rates of transport of several natural amino 
acids. The transport of gl cine, serine, alanine, and proline, amino acids transported 
mainly by the A system,‘ was inhibited 50% to 85% by dexamethasone. Transport 
of amino acids thought to be transported mainly by the L system (phenylalanine, 
leucine, and valine) was also inhibited, although to a lesser extent. Detailed kinetic 
analysis of glycine transport by hepatoma cells revealed at least two separate transport 
systems. One system is characterized by low afinity (Km = 5.1 mM) and high 
capacity for glycine transport. This system appears to be analogous to the A-transport 
system described in other cell types because it is sodium and pH-dependent, and 
mediates the bulk of AIB transport. The other transport system is characterized by 
higher affinity (Km = 0.23 mM) and lower capacity for glycine transport, is also 
sodium-dependent, but is not inhibited at low pH. The pattern of inhibition of the 
latter system by various amino acids and analogs differs from that of any previously 
characterized transport system in animal cells. Both transport systems for glycine are 
214 
strikingly inhibited by dexamethasone; however, the time course of the glucocorticoid 
inhibition of the low-affinity, high-capacity system is much more rapid. Glutamic 
acid uptake by HTC cells is also markedly inhibited by dexamethasone, and appears 
to be mediated by one or more transport agencies distinct from either of the glycine 
transport systems. Therefore, dexamethasone appears to inhibit the activity of at least 
three discrete amino acid transport systems in rat hepatoma cells.6 This finding is in 
contrast to the generally held belief that hormones and other modulators of transport 
affect solely or primarily the A system.% 
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Glucocorticoid Regulation of Plasminogen Activator 
Many transformed cells roduce increased amounts of proteolytic enzymes, such 
as plasminogen activator?'*' The production of such proteases has received special 
attention because of the pleiotropic effects of these enzymes on membrane structure 
and function, and because of their important role in biological 
Proteolytic removal or alteration of a limited number of membrane proteins could 
have diverse effects on the behavior of many cell surface proteins, by influencing 
either their mobility within the membrane or their interaction with each other and 
with the interior of the cell. 
Wigler et al. first reported that HTC cells produced large amounts of plasminogen 
activator, and that this activity is dramatically and rapidly inhibited by treatment of 
the cells with dexamethasone." We have confirmed these observations and have 
investigated the mechanism by which glucocorticoids inhibit the activity of this serine 
protease. The time course of inhibition of intracellular PA activity by dexamethasone 
is shown in FIGURE 2. PA activity is measured by the solubilization of '251-fibrin; 
fibrinolytic activity in HTC cells is entirely dependent on the presence of plasmino- 
gen. Dexamethasone, after a short lag, causes a rapid inhibition of PA activity, which 
is maximal in 3 to 5 hours and is half-maximal after approximately 90 minutes 
incubation with the hormone. The direct addition of dexamethasone to the assay has 
no effect on fibrinolytic activity.I2 
The inhibition of plasminogen activator could involve a decrease in the amount 
of PA secondary to a decrease in its rate of synthesis or increase in its rate of 
degradation, or the induction of an inhibitor of PA activity, or a combination of 
these mechanisms. Mixing experiments were carried out in which increasing amounts 
of cell extracts of hormone-treated cells were incubated with a constant amount of 
cell extract of untreated cells as a source of PA activity. The concentration-dependent 
inhibition of PA activity in such mixtures revealed the presence of an inhibitory 
activity in dexamethasone-treated cells.12 Cell fractionation experiments indicated 
that PA activity is localized to the particulate (lo0,OOO X g pellet) fraction whereas 
the inhibitory activity is found primarily in the soluble cytoplasmic fraction (1o0,OOO 
x g supernatant). However, inhibitory activity is also found in the particulate 
fraction, and in the serum-free medium conditioned by dexamethasone-treated cells. 
Genetic Approaches to the Hormonal Regulation of Plasma Membrane Phenorype 
In order to investigate the mechanisms by which steroids induce the membrane 
changes described above, it would be helpful to have mutants or variants resistant to 
the regulatory effects of glucocorticoids. Since glucocorticoids do not kill or alter the 
growth or plating efficiency of HTC cells on plastic or in agar,'3s38 there are no 
obvious selective systems by which to isolate dexamethasone-resistant cells. Instead, 
we have utilized an agar-fibrin overlay techniquem to detect the production of 
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FIGURE 2. Time course of dexamethasone inhibition of plasminogen activator. HTC cells 
were incubated overnight in serum-free medium and then incubated in the presence or absence 
of I pM dexamethasone. Triton extracts of cells were assayed on '251-fibrin-coated plates, and 
results normalized for the amount of protein in each sample. Each p in t  represents the average 
of duplicate assays on a single culture. (From Seifert & Gelehrter.' By permission of National 
Academy of Sciences.) 
plasminogen activator by individual colonies of HTC cells."*I3 This technique is not 
selective, but it is not destructive and allows recovery of selected colonies through 
the agar overlay and their subsequent propagation. Nine hormone-resistant variant 
cell lines have been isolated. The resistant phenotype has been stably inherited in 
three of these variants for over 300 generations in the absence of dexamethasone. 
The degree of glucocorticoid resistance of these three lines is illustrated in FIGURE 3. 
PA activity in wild-type cells is half-maximally inhibited by 5 nM dexamethasone 
and completely inhibited by concentrations greater than 10 nM. Variant cell lines 
are fully resistant to concentrations of dexamethasone 1,OOO times those required to 
completely inhibit PA activity in wild-type cells.13 
Each variant appears to possess distinct morphology; however, there appears to 
be no single consistent morphology associated with resistance to dexamethasone 
inhibition of PA activity. The cloning efficiencies of 3 variant lines tested is the same 
as that of wild-type cells (40% to 600/0), and in no case are these efficiencies altered 
by dexamethasone. The growth of wild-type and variant cells in both monolayer and 
suspension culture appears to be the same. Thus regulation of rowth and regulation 
The origin of the resistant phenotype is not entirely clear. Fluctuation analyses 
demonstrate that the dexamethasone-resistant phenotype arises at random and is 
present prior to exposure to the hormone. Thus the variants are not induced by 
exposure to dexamethasone. On the other hand, neither chemical (ethyl methane- 
sulfonate) nor physical (ultraviolet light) mutagens detectably increased the frequency 
with which the dexamethasone-resistant phenotype is observed. These observations 
argue against mutations as the primary cause of resistance to dexamethasone. Because 
of this serine protease are obviously dissociated in HTC cells. k.14 
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FIGURE 3. Concentration-dependence of dexamethasone inhibition of plasminogen acti- 
vator in wild-type and steroid-resistant HTC cells. Cells were incubated with the concentrations 
of dexamethasone indicated for 18 hours, and intracellular fibrinolytic activity assayed. In order 
to facilitate comparison, results for each cell line are expressed as the percentage of activity of 
the respective untreated cells. Each point represents the average of duplicate assays performed 
on a single culture. Symbols: control (0); variant A 0; variant B (A); variant C (V). (From 
Seifert & Gelehrter.13 By permission of Journal of Cellular Physiology.) 
HTC cells are heteroploid and karyotypically highly variable, variants are thought 
to arise primarily by chromosomal segregation events.13 
The mechanism of resistance to dexamethasone inhibition of plasminogen acti- 
vator in the variant cell lines could be the result of a failure of the hormone to induce 
the inhibitor, or to the production of a plasminogen activator that is resistant to the 
action of the inhibitor. We have attempted to distinguish between these hypotheses 
by carrying out the mixing experiments shown in FIGURE 4. In the experiment 
depicted in panel A, increasing amounts of an extract of dexamethasone-treated 
variant cells were added to a constant amount of extract of untreated wild-type cells 
(as a source of plasminogen activator activity). There is no evidence of any inhibition 
of plasminogen activator activity by the extract of dexamethasone-treated variant 
cells. In contrast, as shown in panel B, the addition of increasing amounts of extract 
of dexamethasone-treated wild-type cells to a constant amount of extract from 
untreated variant cells demonstrates a concentration-dependent inhibition of protease 
activity. These observations indicate that the plasminogen activator produced by the 
variant cell line is fully sensitive to inhibition by inhibitor from wild-type cells; in 
contrast, there appears to be no inhibitor in the dexamethasone-treated variant cell 
line." Identical results have been obtained with two other variant cell lines tested. 
In contrast to most reported glucocorticoid-resistant variant cells lines,"" these 
variants are unique because resistance is not secondary to defective or absent 
glucocorticoid receptors. This interpretation is based on the finding that dexameth- 
asone induces tyrosine aminotransferase to the same extent and with the same time 
Gelehrter: Hormonal Regulation 217 
0.2 0.4 0.6 0.8 1.0 
pg protein Var A 
40 
20 
0 5 10 15 
pg protein wild-type 
FIGURE 4. Dexamethasone induces an inhibitor of plasminogen activator in wild-type cells 
but not in variant cells. (A) Increasing amounts of an extract of dexamethasone-treated variant 
cells were mixed with a futed amount of extract of untreated wild-type cells prior to assaying 
PA activity on '"I-fibrin-coated plates. (B) Increasing amounts of an extract of dexamethasone- 
treated wild-type cells were mixed with a futed amount of extract of untreated variant cells 
prior to assaying in a similar fashion 0. Shown for comparison is the fibrinolytic activity of 
increasing amounts of extract of untreated (0) and dexamethasone-treated (0) wild-type cells 
assayed in the same fashion. (From Carlson Br Gelehrter." By permission of Journal of 
Supramolecular Siructure. ) 
course in the variant lines as in wild-type HTC cells.",13 Because the induction of 
tyrosine aminotransferase requires an intact glucocorticoid receptor capable of being 
translocated to the nucleus, these observations suggest that the proximal steps in the 
glucocorticoid receptor pathway are intact in these variants, and that the resistance 
is due to a more distal lesion in the pathway of hormonal inhibition of PA. 
The selectivity of the hormone resistance in these variants has been studied by 
examining the ability of dexamethasone to inhibit AIB transport. The velocity of 
AIB transport by wild-type and variant cell lines in the absence of dexamethasone 
was similar. Eight of nine variant Lines tested showed wild-type inhibition of AIB 
Thus these variants do not show a general resistance to all membrane- 
associated dexamethasone responses, and it can be concluded that these two mem- 
brane properties are independently regulated by dexamethasone. Interestingly, one 
variant did show partial resistance to inhibition of AIB transport by dexamethasone; 
this resistance was manifest even at concentrations of dexamethasone as high 10 
pM.I3 
Role of Plasminogen Activator in the Dexamethasone 
Regulation of Cellular Adhesiveness 
We have utilized the dexamethasone-resistant variants to analyze the mechanism 
of dexamethasone regulation of other membrane properties, such as the induction of 
adhesion in HTC cells.' We have directly tested the hypothesis that dexamethasone 
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induces cell adhesiveness by decreasing the activity of plasmhogen activator, which, 
in turn, allows the accumulation of specific membrane glycoproteins necessary for 
adhesion. If this hypothesis were correct, there should be little or no dexamethasone 
induction of adhesion in the variant cell lines resistant to the inhibition of PA. We 
have reported that, in fact, dexamethasone induces the adhesiveness of three of three 
variant HTC cell lines tested to a similar extent as in wild-type cells?" Experiments 
with one variant are shown in FIGURE 5 .  These observations suggest that the 
dexamethasone induction of adhesion probably operates primarily through the 
synthesis of cell surface glycoproteins and that this process in turn is not regulated by 
the inhibition of PA activity. 
Thus, dexamethasone-resistant variant cell l i e s  have been useful in studying the 
role of proteases in the hormonal regulation of other membrane functions. In the 
case of the induction of cellular adhesiveness, they have allowed the clear exclusion 
of a plausible hypothesis for the mechanism of induction of adhesiveness. Studies 
with these variants also indicate that the inhibition of AIB transport is not secondary 
to an inhibition of PA activity, since variants resistant to the latter effect retain 
normal inhibition of transport. Because these variant cell lines also retain wild-type 
induction of tyrosine aminotransferase as well as inhibition of amino acid transport 
and induction of adhesiveness, it appears the process or processes in hormonal 
regulation that are defective in these variants are not shared in the regulation of 
other hormone-induced events. Such a conclusion is also supported by our studies 
with Thompson et 01. utilizing other HTC cell variants in which tyrosine aminotrans- 
ferase is not inducible. These noninducible variants have retained wild-type gluco- 
corticoid regulation of such membrane properties as AIB transport and PA activity?' 
Cell hybridization experiments between variants resistant to enzyme induction and 
others resistant to the inhibition of PA activity should help in unraveling the 
mechanisms by which glucocorticoids regulate these functions in HTC cells. Finally, 
these variants provide a powerful tool for analyzing the hormonal regulation of 
membrane and secretory proteins in HTC cells?3 Comparison of the patterns of 
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FIGURE 5. Dexamethasone induction of cellular adhesiveness in wild-type and variant 
HTC cells. Wild-type (a) or variant (b) HTC cells were incubated for 18 hours in serum-free 
medium containing bovine serum albumin in the presence (0) or absence (0) of 0.1 pM 
dexamethasone. Adhesion was assayed as described by Fredin er al.' Each point represents the 
mean f SEM of 9 experiments (a) and 4 experiments (b). (From Gelehrter er ul." By permission 
of Cold Spring Harbor Laboratory.) 
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synthesis of membrane and secretory proteins in dexamethasone-treated wild-type 
cells with those in variant cells with selective lesions in hormone responsiveness 
should help in both the identification and isolation of specific hormonally-induced 
proteins. 
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